Engineer In Hoboken Train Crash Had Undiagnosed Sleep Apnea
HOBOKEN — The engineer of a commuter train that slammed into a station going double the 10 mph speed limit, killing a woman, suffered from sleep apnea that had gone undiagnosed, two U.S. officials told The Associated Press on Wednesday.
One official said investigators are looking at it as a potential cause.
The officials, who were briefed on the investigation, spoke to The Associated Press on the condition of anonymity because they weren’t authorized to discuss the matter.
They said the engineer, 48-year-old Thomas Gallagher, was diagnosed with sleep apnea after the Sept. 29 crash in Hoboken, the officials said.
Sleep apnea robs its victims of rest because they are repeatedly awakened as their airway closes and their breathing stops, leading to dangerous daytime drowsiness.
The same condition went undiagnosed in the engineer of a commuter train that sped into a curve and crashed in New York City in 2013, killing four people.
A union representing Gallagher didn’t immediately respond to a message seeking comment. NJ Transit also did not respond to a message.
A spokesman for the National Transportation Safety Board said the agency was not in a position to confirm specifics of the engineer’s health.
“These are matters that are being looked at as part of the NTSB’s comprehensive investigation of the Hoboken accident,” said NTSB spokesman Christopher O’Neil.
NJ Transit tests engineers for sleep apnea.
One of the officials briefed on the investigation said given the screening program, it’s “not clear why he wasn’t screened or if he was, how he passed.”
Gallagher, a NJ Transit engineer for about 18 years, told investigators he had no memory of the crash and only remembered waking up on the floor of the engineer’s cab. He was pulled from the wreckage, treated at a hospital and released.
To read the rest of this article, click here:
You can buy CPAP Machines, tubing and all of your CPAP supplies at CPAP America, 707 Mantua Pike, West Deptford, NJ 08096. Feel free to contact us at 1-800-569-0167.
You can also reach us via email here.